Petitions | The White House
Showing posts with label open access. Show all posts
Showing posts with label open access. Show all posts
Monday, May 21, 2012
Petitions | The White House re: free access to scientific journal articles....
Petitions | The White House
Wednesday, May 09, 2012
Drug Data Shouldn’t Be Secret - NYTimes.com
Drug Data Shouldn’t Be Secret - NYTimes.com
"We should not have to wait for patients to be hurt by the medications they take, as recently happened with the diabetes drug Avandia, before reviewing this wealth of data."
Wednesday, April 25, 2012
Friday, March 02, 2012
The silent minority - unpublished data on cancer care - Impact Factor - Isseus 46 - Articles - Cancer World
The silent minority - unpublished data on cancer care
From 1989 to 2003, 709 phase III trials evaluating systemic cancer treatment were presented at ASCO meetings. Tam and collaborators have now reported that 9% of these trials were never published, and 13% were published after a five-year delay. More than half of these studies would have had clinical impact if published promptly.
» Daniel F. Hayes
Two key elements of the scientific method are methodology transparency and reproducibility of results by others. Traditionally, these elements have been facilitated by the well-entrenched system of peer-review publication. This concept has had almost universal acceptance among the scientific community, although in the past few years there have been calls for open publication of all scientific results without the peer-review process. Some experts have advocated the creation of a type of ‘free-for-all’ post-publication peer review, with the view that classic, pre-publication peer review is usually selective (based on whom the editor knows and on who actually agrees to referee the article) and arbitrary (based on the respective biases of the reviewers).[1]........
Friday, February 24, 2012
open access publisher: Hindawi Publishing Corporation
Hindawi Publishing Corporation Hindawi is a rapidly growing academic publisher with more than 300 Open Access journals covering a wide range of academic disciplines.
Thursday, February 16, 2012
Saturday, February 04, 2012
The Cost of Knowledge - petition to allow open access publishing - Elsevier journals
Blogger's Note: Gynecologic Oncology is a journal published through Elsevier
Friday, February 03, 2012
Stem Cell Network Blog: News roundup: open access, new funding for personalized medicine and spinal cord injury update (eg. Elsevier - subscriber-based publisher)
February 01, 2012
News roundup: open access, new funding for personalized medicine and spinal cord injury update
Some updates and news items of note:
Call for boycott of subscriber-based journals gains momentum
The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most notably from prominent British mathmetician Tim Gowers, who publicly announced his decision to stop submitting and reviewing for Elsevier. His objections are worth reading. Within days of his comments, a web site was created that allows other researchers to pledge their support for open access and against the practices of Elsevier and other academic publishers. At time of writing, there were over 2400 signatures. Of course, this is not the first time such calls for open access have surfaced from within the research community, the last big push resulted in the formation of the Public Library of Science in 2000.....
(open access publisher) BioMed Central Blog : OSTP publishes public comments in response to RFIs on public access to publications and data
BioMed Central Blog 
Friday Feb 03, 2012
BioMed Central responded to both Requests for Information, and our contributions are now publicly available online:
Tuesday, January 24, 2012
open access: Journal of Translational Medicine - Supporting the advancement of science: Open access publishing and the role of mandates (the Research Works Act[1])
The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.
excerpt pdf file:"In December 2011 the United States House of Representatives introduced a new bill, the Research Works Act (H.R.3699), which if passed could threaten the public’s access to US government funded
research. In a digital age when professional and lay parties alike look more and more to the online environment to keep up to date with developments in their fields, does this bill serve the best
interests of the community? Those in support of the Research Works Act argue that government open access mandates undermine peer-review and take intellectual property from publishers without compensation, however journals like Journal of Translational Medicine show that this is not the case. Journal of Translational Medicine in affiliation with the Society for Immunotherapy of Cancer demonstrates how private and public organisations can work together for the advancement
of science.
Editorial
Journal of Tra nslational Medicine is an open access journal published by BioMed Central that aims to optimise communication between basic and clinical science. Now in its 10th year of publication
the journal is successful in its aim for fostering communication from bench to bedside.
A new bill, the Research Works Act[1], has been introduced in the United States House of Representatives threatening the public’s access to US government funded research and the foundation on which Journal of Translational Medicine was built.
The bill states:
“No Federal agency may adopt, implement, maintain, continue, or otherwise engage in any policy, program, or other activity that:
(1) causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher of such work; or (2) requires that any actual or prospective author, or the employer of such an actual or prospective author, assent to network dissemination of a private-sector research work.”
If passed, this bill would force the retraction of the public access policy of the National Institutes of Health[2], who mandate that recipients of their grants must make their published research publically accessible by depositing full-text versions in open access repositories (such as PubMed Central), and prevent similar policies from being introduced by federal agencies in the future.
It is argued [3, 4] that research funded by tax-payers should be made available to the public free of charge so that the tax-payer does not in effect pay twice for the research - first for the research to be done and then to read the results. As much as this may be true, the biggest detriment seems to be to developments in science. Open access to research means the widest possible dissemination of information. Limiting access to a (by comparison) small subset of people with subscriptions can stunt further developments......"
Monday, January 16, 2012
Major Cancer Societies to Support New Wiley Open Access Journal
January 16, 2012 – Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., today announced the launch of Cancer Medicine, a new Wiley Open Access journal. Cancer Medicine is a peer reviewed, open access, interdisciplinary journal providing rapid publication of cutting edge research from global biomedical and clinical researchers across all the oncologic specialties in cancer biology, clinical cancer research and cancer prevention. The journal’s promise of full global reach is reinforced by its editorial leadership and support from prestigious journals and societies. Cancer Medicine has unprecedented support from three major cancer societies......
Dr. Wei (Editor in Cheif) comments, “I am delighted to introduce Cancer Medicine, which will allow readers to have fast access to the most up to date global collaborations in cancer research and international approaches in practicing cancer medicine, as well as highlighting key achievements from the integration of basic, clinical and preventive research of cancer. In the years to come, I will work closely with the Wiley-Blackwell Cancer Medicine team to provide timely and impartial service to all contributors and readers, who will, without a doubt, make Cancer Medicine a success.”
The journal is open to submissions now and aims to publish its first content online in Spring 2012. Please visit the journal’s website www.cancermedicinejournal.com for further information and future updates.
Thursday, January 12, 2012
new open access journal Feb 2012 - Journal of Clinical Gynecology and Obstetrics
Journal of Clinical Gynecology and Obstetrics
ISSN 1927-1271 print, 1927-128X online.Journal of Clinical Gynecology and Obstetrics is a bimonthly, international, open access, peer-reviewed journal, publishes original contributions describing basic research and clinical investigation of gynecology and obstetrics, on the cellular, molecular, prevention, diagnosis, therapy and prognosis aspects.
Journal of Clinical Gynecology and Obstetrics is published both in print and online, it is an open access journal, all its contents are available online for free immediately after publication, this supports a greater global exchange of knowledge, meanwhile, the authors' new findings are disseminated faster and wider.
Journal of Clinical Gynecology and Obstetrics will be launched in February 2012.
Wednesday, January 11, 2012
Research Bought, Then Paid For - NYTimes.com
"THROUGH the National Institutes of Health, American taxpayers have long supported research directed at understanding and treating human disease. Since 2009, the results of that research have been available free of charge on the National Library of Medicine’s Web site, allowing the public (patients and physicians, students and teachers) to read about the discoveries their tax dollars paid for."
"But a bill introduced in the House of Representatives last month threatens to cripple this site. The Research Works Act would forbid the N.I.H. to require, as it now does, that its grantees provide copies of the papers they publish in peer-reviewed journals to the library. If the bill passes, to read the results of federally funded research, most Americans would have to buy access to individual articles at a cost of $15 or $30 apiece. In other words, taxpayers who already paid for the research would have to pay again to read the results...."
Bill Blocking NIH Public Access Policy Draws Fire - ScienceInsider
"A little-noticed proposal in Congress to block a federal policy requiring free access to biomedical research papers went big time today, adding fuel to a long-running debate in the blogosphere...."
New Bill Aims to Kill Open Access Publishing Policy | GenomeWeb Daily News | GenomeWeb
Blogger's Note: requires registration to view (free)
"NEW YORK (GenomeWeb News) – A new bill in the US House of Representatives that seeks to prevent federal agencies from requiring open-access publishing of government-funded research would effectively nullify a public access policy that the National Institutes of Health implemented in 2008....The White House has been collecting comments in response to a request for information on the subject, and will continue accepting them until tomorrow, Jan. 12."
collecting comments link as above:
Extended Deadline for Public Access and Digital Data RFIs
Wednesday, February 17, 2010
Subscribe to:
Posts
(
Atom
)
